{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:38:50Z","timestamp":1787027930866,"version":"build-2736575974"},"reference-count":48,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T00:00:00Z","timestamp":1703203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>This study aimed to investigate the relationship between rosacea and headaches, focusing on different subtypes, as well as the associated clinical features and triggering factors. In this prospective study, 300 patients diagnosed with rosacea and 320 control subjects without rosacea or any connected mast cell activation illness were included. Patients with rosacea were assessed by a dermatologist according to the 2019 updated rosacea classification (ROSCO panel). Accordingly, patients were classified based on their predominant rosacea subtype as follows: erythematotelangiectatic (ETR), papulopustular (PPR), or phymatous (RhR). Patients experiencing headaches were assessed using the International Headache Classification. Headaches were categorized as migraine, tension-type headaches (TTHs), secondary types (STHs), and cluster-type headaches (CTHs). The ratio of headache was 30.3% in the rosacea group, which did not show a significant difference compared to the control group (30.3% vs. 25.0%, p = 0.138). In 81.3% of rosacea patients with headaches, headache onset occurred after the diagnosis of rosacea. The rate of patients with headaches was higher in the ETR group compared to the PPR and RhR groups (35.2% vs. 16.2% vs. 23.1%, p = 0.007, respectively). In terms of headache subtypes, the rates of patients with migraine and STHs were higher in the ETR group compared to the PPR and RhR groups, while the rate of patients with TTHs was higher in the RhR group. A positive correlation was found between rosacea severity and migraine severity (r = 0.284, p &lt; 0.05). Among the triggering factors for rosacea, only sunlight was found to be associated with headaches. Lower age, female gender, and moderate to severe rosacea severity were identified as independent factors increasing the likelihood of headaches. A significant portion of rosacea patients experience headaches. Particularly, different subtypes of rosacea may be associated with various types of headaches. This study, highlighting the connection between migraine and ETR, is a pioneering work that demonstrates common pathogenic mechanisms and potential triggers.<\/jats:p>","DOI":"10.3390\/diagnostics14010023","type":"journal-article","created":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T04:44:40Z","timestamp":1703220280000},"page":"23","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of Dermatological and Neurological Aspects of the Relationship between Rosacea and Headaches"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2732-9132","authenticated-orcid":false,"given":"Merve","family":"Alizada","sequence":"first","affiliation":[{"name":"Department of Dermatology, Mamak State Hospital, 06230 Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turgut","family":"Sahin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Cank\u0131r\u0131 State Hospital, 18100 \u00c7ank\u0131r\u0131, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozden","family":"Sener","sequence":"additional","affiliation":[{"name":"Department of Neurology, Ankara University Faculty of Medicine, 06100 Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pelin","family":"Kocyigit","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Ankara University Faculty of Medicine, 06100 Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e1361574","DOI":"10.1080\/19381980.2017.1361574","article-title":"Rosacea: Epidemiology, pathogenesis, and treatment","volume":"9","author":"Rainer","year":"2017","journal-title":"Dermatoendocrinology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/bjd.20578","article-title":"Male patients with rosacea have increased risk for migraine: A population-based study","volume":"185","author":"Sinikumpu","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jaad.2016.08.055","article-title":"Prevalence and risk of migraine in patients with rosacea: A population-based cohort study","volume":"76","author":"Egeberg","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Woo, Y.R., Han, Y.J., Kim, H.S., Cho, S.H., and Lee, J.D. (2020). Updates on the risk of neuropsychiatric and gastrointestinal comorbidities in rosacea and its possible relationship with the gut-brain-skin axis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228427"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1177\/0333102417731777","article-title":"The relationship between migraine and rosacea: Systematic review and meta-analysis","volume":"38","author":"Christensen","year":"2018","journal-title":"Cephalalgia"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jaad.2013.03.027","article-title":"Migraine, triptans, and the risk of developing rosacea: A population-based study within the United Kingdom","volume":"69","author":"Spoendlin","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3390\/dermato3040019","article-title":"Rosacea: An overview of its etiological factors, pathogenesis, classification and therapy options","volume":"3","author":"Maden","year":"2023","journal-title":"Dermato"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e10874","DOI":"10.1016\/j.heliyon.2022.e10874","article-title":"Current research and clinical trends in rosacea pathogenesis","volume":"8","author":"Hu","year":"2022","journal-title":"Heliyon"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e039445","DOI":"10.1136\/bmjopen-2020-039445","article-title":"Cohort profile: COpenhagen ROsacea COhort (COROCO) and COpenhagen MIgraine COhort (COMICO)","volume":"10","author":"Wienholtz","year":"2020","journal-title":"BMJ Open"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/2049463712459691","article-title":"Headache disorders: Differentiating and managing the common subtypes","volume":"6","author":"Ahmed","year":"2012","journal-title":"Br. J. Pain"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/bjd.18420","article-title":"Recommendations for rosacea diagnosis, classification and management: Update from the global ROSacea COnsensus 2019 panel","volume":"182","author":"Schaller","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jaad.2004.01.048","article-title":"Standard grading system for rosacea: Report of the National Rosacea Society Expert Committee on the classification and staging of rosacea","volume":"50","author":"Wilkin","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S1474-4422(18)30085-1","article-title":"International classification of headache disorders","volume":"17","author":"Olesen","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1212\/WNL.56.suppl_1.S20","article-title":"Development and testing of the migraine disability assessment (MIDAS) questionnaire to assess headache-related disability","volume":"56","author":"Stewart","year":"2001","journal-title":"Neurology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/j.1468-2982.2008.01833.x","article-title":"A vertical VAS is a valid instrument for monitoring headache pain intensity","volume":"29","author":"Lundqvist","year":"2009","journal-title":"Cephalalgia"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s10194-022-01402-2","article-title":"The global prevalence of headache: An update, with analysis of the influences of methodological factors on prevalence estimates","volume":"23","author":"Stovner","year":"2022","journal-title":"J. Headache Pain"},{"key":"ref_17","first-page":"17","article-title":"Headache: Tension-Type Headache","volume":"473","author":"Scripter","year":"2018","journal-title":"FP Essent."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11910-021-01138-7","article-title":"Current Understanding of the Pathophysiology and Approach to Tension-Type Headache","volume":"21","author":"Steel","year":"2021","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e20230256","DOI":"10.1590\/1806-9282.20230256","article-title":"\u201cZooming\u201d in the association between rosacea and fibromyalgia syndrome: Is it worth mentioning?","volume":"69","author":"Sengul","year":"2023","journal-title":"Rev. Assoc. M\u00e9dica Bras."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/jidsymp.2011.9","article-title":"Rosacea: The cytokine and chemokine network","volume":"15","author":"Gerber","year":"2011","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1026447","DOI":"10.3389\/fmed.2022.1026447","article-title":"Clinical characteristics of combined rosacea and migraine","volume":"9","author":"Wienholtz","year":"2022","journal-title":"Front Med"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.2147\/CCID.S413237","article-title":"New insights into the mutual promotion of rosacea, anxiety, and depression from neuroendocrine immune aspects","volume":"16","author":"Yang","year":"2023","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00281-018-0676-y","article-title":"Neurogenic inflammation and its role in migraine","volume":"40","author":"Ramachandran","year":"2018","journal-title":"Semin. Immunopathol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.brainresrev.2004.11.006","article-title":"The role of mast cells in migraine pathophysiology","volume":"49","author":"Theoharides","year":"2005","journal-title":"Brain Res. Brain Res. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00540-018-2579-4","article-title":"Roles of inflammation, neurogenic inflammation, and neuroinflammation in pain","volume":"33","author":"Matsuda","year":"2019","journal-title":"J. Anesth."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"100361","DOI":"10.1016\/j.bbih.2021.100361","article-title":"Roles of calcitonin gene-related peptide in the skin, and other physiological and pathophysiological functions","volume":"18","author":"Kim","year":"2021","journal-title":"Brain Behav. Immun. Health"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Karsan, N., Gosalia, H., and Goadsby, P.J. (2023). Molecular mechanisms of migraine: Nitric oxide synthase and neuropeptides. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241511993"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/jidsymp.2011.6","article-title":"Neurovascular and neuroimmune aspects in the pathophysiology of rosacea","volume":"15","author":"Schwab","year":"2011","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"512","DOI":"10.2340\/00015555-1775","article-title":"Calcipotriol increases hCAP18 mRNA expression but inhibits extracellular LL37 peptide production in IL-17\/IL-22-stimulated normal human epidermal keratinocytes","volume":"94","author":"Sakabe","year":"2014","journal-title":"Acta Derm. Venereol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Woo, Y.R., Lim, J.H., Cho, D.H., and Park, H.J. (2016). Rosacea: Molecular mechanisms and management of a chronic cutaneous inflammatory condition. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17091562"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/jocd.14169","article-title":"Serum IL-17 levels in patients with rosacea","volume":"21","author":"Hayran","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"41779","DOI":"10.1038\/srep41779","article-title":"IL-17 induces reactive astrocytes and up-regulation of vascular endothelial growth factor (VEGF) through JAK\/STAT signaling","volume":"7","author":"You","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejphar.2018.12.004","article-title":"Progression in migraine: Role of mast cells and pro-inflammatory and anti-inflammatory cytokines","volume":"844","author":"Conti","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"ref_34","first-page":"952906","article-title":"Matrix metalloproteinases in neuropathic pain and migraine: Friends, enemies, and therapeutic targets","volume":"2012","author":"Lakhan","year":"2012","journal-title":"Pain Res. Treat."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Yamanaka, G., Hayashi, K., Morishita, N., Takeshita, M., Ishii, C., Suzuki, S., Ishimine, R., Kasuga, A., Nakazawa, H., and Takamatsu, T. (2023). Experimental and clinical investigation of cytokines in migraine: A narrative review. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24098343"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1468-3083.2009.03472.x","article-title":"Risk factors associated with rosacea","volume":"24","author":"Abram","year":"2010","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/ene.12451","article-title":"Photic hypersensitivity in the premonitory phase of migraine\u2014A positron emission tomography study","volume":"21","author":"Maniyar","year":"2014","journal-title":"Eur. J. Neurol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11916-018-0734-0","article-title":"Triggers, protectors, and predictors in episodic migraine","volume":"22","author":"Marmura","year":"2018","journal-title":"Curr. Pain Headache Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.jaad.2013.04.045","article-title":"New insights into rosacea pathophysiology: A review of recent findings","volume":"69","author":"Steinhoff","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1468-2982.2007.01303.x","article-title":"The triggers or precipitants of the acute migraine attack","volume":"27","author":"Kelman","year":"2007","journal-title":"Cephalalgia"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s13555-021-00613-w","article-title":"Depression and Anxiety in Rosacea Patients: A Systematic Review and Meta-Analysis","volume":"11","author":"Dai","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jid.2016.12.013","article-title":"TRPV4 moves toward center-fold in rosacea pathogenesis","volume":"137","author":"Chen","year":"2017","journal-title":"J. Investig. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Benemei, S., and Dussor, G. (2019). TRP channels and migraine: Recent developments and new therapeutic opportunities. Pharmaceuticals, 12.","DOI":"10.3390\/ph12020054"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.3349\/ymj.2014.55.6.1648","article-title":"Increased expression of cathelicidin by direct activation of protease-activated receptor 2: Possible implications on the pathogenesis of rosacea","volume":"55","author":"Kim","year":"2014","journal-title":"Yonsei Med. J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1001\/archdermatol.2010.413","article-title":"Neurogenic rosacea: A distinct clinical subtype requiring a modified approach to treatment","volume":"147","author":"Scharschmidt","year":"2011","journal-title":"Arch. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ncl.2019.06.001","article-title":"Migraine: Epidemiology, burden, and comorbidity","volume":"37","author":"Burch","year":"2019","journal-title":"Neurol. Clin."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0333102417738202","article-title":"Headache Classification Committee of the International Headache Society (IHS) the International Classification of Headache Disorders, 3rd edition","volume":"38","author":"Arnold","year":"2018","journal-title":"Cephalalgia"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1468-2982.1999.019002107.x","article-title":"Reliability of the migraine disability assessment score in a population-based sample of headache sufferers","volume":"19","author":"Stewart","year":"1999","journal-title":"Cephalalgia"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/1\/23\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:40:21Z","timestamp":1760132421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/1\/23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,22]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["diagnostics14010023"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics14010023","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,22]]}}}